Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aclaris Therapts (ACRS)

Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Biotech Sector Advances in Pancreatic Cancer Research

USA News Group – Known as one of the most deadly forms of cancer, pancreatic cancer still has the highest mortality rate of all major cancers today. However, researchers and the biotech sector are working...

BRX : 21.43 (+0.56%)
ONCY : 1.0350 (+0.49%)
ONC.TO : 1.42 (-0.70%)
NVS : 94.40 (+1.98%)
IBRX : 5.24 (+6.72%)
ACRS : 1.2450 (+1.22%)
NUVB : 2.51 (-2.71%)
Biotech’s Role in Addressing the Pancreatic Cancer Emergency

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVX),(NASDAQ:IBRX),(NASDAQ:ACRS),(NYSE:NUVB) EQNX::TICKER_END

NVX : 2.30 (-2.54%)
ONCY : 1.0350 (+0.49%)
ONC.TO : 1.42 (-0.70%)
NVS : 94.40 (+1.98%)
IBRX : 5.24 (+6.72%)
ACRS : 1.2450 (+1.22%)
NUVB : 2.51 (-2.71%)
Aclaris: Q4 Earnings Snapshot

Aclaris: Q4 Earnings Snapshot

ACRS : 1.2450 (+1.22%)
Aclaris: Q3 Earnings Snapshot

Aclaris: Q3 Earnings Snapshot

ACRS : 1.2450 (+1.22%)
Why Aclaris Therapeutics Stock Soared Nearly 6% on Thursday

A bull on the company became more positive on its prospects.

SF : 75.07 (+0.25%)
ACRS : 1.2450 (+1.22%)
Aclaris: Q2 Earnings Snapshot

Aclaris: Q2 Earnings Snapshot

ACRS : 1.2450 (+1.22%)
2 Low-Priced Stocks That Could Make You Richer

These two low-priced healthcare stocks could skyrocket within the next 12 months.

GILD : 66.72 (+0.85%)
INCY : 52.18 (-1.21%)
VKTX : 63.10 (-2.43%)
AXSM : 67.67 (+2.97%)
MRK : 125.94 (+0.57%)
BMY : 48.91 (+1.26%)
AGEN : 5.25 (+5.63%)
ACRS : 1.2450 (+1.22%)
Why Aclaris Therapeutics Topped the Market on Tuesday

Investors were cheered by the latest laboratory news from the company.

ACRS : 1.2450 (+1.22%)
Aclaris Therapeutics (ACRS) Reports Q1 Loss, Tops Revenue Estimates

Aclaris (ACRS) delivered earnings and revenue surprises of 4.55% and 36.06%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ACRS : 1.2450 (+1.22%)
ACRX : 0.8600 (+7.50%)
Aclaris: Q1 Earnings Snapshot

Aclaris: Q1 Earnings Snapshot

ACRS : 1.2450 (+1.22%)

Barchart Exclusives

Up 67% YTD, Is Soundhound AI Overvalued?
Soundhound AI's shares have surged, thanks to Nvidia's investment in the company and growing enthusiasm surrounding AI. After a steep pullback, is the stock still overvalued? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar